Research roundup: diagnostic and prognostic cancer markers
Interested in seeing more of our cancer research antibodies in action? The following three studies have successfully utilized different Atlas Antibodies products to suggest or identify new biomarkers for different cancers.
Research roundup: neuroscience antibodies and protein standards
Our highly-validated antibodies and QPrEST protein standards are used in cutting-edge neuroscience research. Read a roundup of some newly published studies to see our neuroscience antibodies and targeted proteomics in action!
Microglia: the brain’s immune barrier at the interface of good and bad
In this blog post, we share an overview of the existing knowledge regarding the neuro-modulatory function of microglia.
Candidate diagnostic biomarkers for lung cancer
In this blog, we discuss the rapidly evolving field of targeted drug therapy in lung cancer.
Keep reading to learn more!
Neuroscience research highlights from SfN 2019
The Annual Society for Neuroscience (SfN) meeting features the latest discoveries in brain research, from the basic mechanisms, to translational and clinical studies. Here are some highlights from the conference.
How can I stain multiple proteins in the same tissue or cell?
Multiplexing-IHC simultaneously quantifies different immune markers on individual cells within different tumor types. But how do you stain multiple proteins in the same cell or tissue?
Cancer research highlights from AACR 2019
From Atlanta, Dr. Kristian Moller, Principal Scientist at Atlas Antibodies, shares the top research highlights from the Annual American Advancement for Cancer Research meeting (AACR) 2019.